Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2014
03/20/2014US20140080858 Abuse-proofed dosage forms
03/20/2014US20140080857 Methods for prophylatic appetite suppression
03/20/2014US20140080856 Crystalline forms of an 8-azabicyclo[3.2.1]octane compound
03/20/2014US20140080855 8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists
03/20/2014US20140080854 Peripheral opioid receptor antagonists and uses thereof
03/20/2014US20140080850 Pharmaceutical composition comprising an omega-3 fatty acid and a hydroxy-derivative of a statin and methods of using same
03/20/2014US20140080849 Small Molecular Inhibitors of RAD51 Recombinase and Methods Thereof
03/20/2014US20140080846 Method of treating orphan respiratry diseases using doxofylline
03/20/2014US20140080845 Use of allopurinol for the treatment of hand foot skin reaction
03/20/2014US20140080841 Chemical Permeation Enhancers Enhance Nerve Blockade by Toxins
03/20/2014US20140080838 Methods for Treatment of Lymphomas with Mutations in Cell Cycle Genes
03/20/2014US20140080837 Sanglifehrin Derivatives and Methods for Their Production
03/20/2014US20140080836 Methods and compositions for treating or preventing erythema
03/20/2014US20140080835 Quinazolinone derivatives as parp inhibitors
03/20/2014US20140080834 Inhibition of adaptor associated kinase 1 for the treatment of pain
03/20/2014US20140080832 IRE-1alpha INHIBITORS
03/20/2014US20140080828 Imidazolyl amide compounds and uses related thereto
03/20/2014US20140080827 Novel kinase modulators
03/20/2014US20140080818 Two-component pharmaceutical composition for the treatment of pain
03/20/2014US20140080815 Dosing regimen for sedation with cns 7056 (remimazolam)
03/20/2014US20140080812 Novel parenteral carbamazepine formulation
03/20/2014US20140080811 Treatment of Alzheimer's Disease Using Compounds that Reduce the Activity of Non-Selective CA++ Activated ATP-Sensitive Cation Channels Regulatd by SUR1 Channels
03/20/2014US20140080810 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture
03/20/2014US20140080807 Substituted indazole derivatives active as kinase inhibitors
03/20/2014US20140080803 Novel trpv3 modulators
03/20/2014US20140080801 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
03/20/2014US20140080798 Vegfr3 inhibitors
03/20/2014US20140080797 Substituted porphyrins
03/20/2014US20140080796 Acetyltanshinone iia (ata) as anticancer agent
03/20/2014US20140080795 NRF2 Deficiency Influences Susceptibility to Steroid Resistance via HDAC2 Reduction
03/20/2014US20140080794 Methods and Compositions for the Treatment of Estrogen-Dependent Hyperproliferative Uterine Disorders
03/20/2014US20140080793 Pharmaceutical compositions with phosphonium antimicrobial agents
03/20/2014US20140080791 Omega-3 phospholipid supplements for females
03/20/2014US20140080789 Method of Treating Diabetes, Glucose Intolerance, Insulin Resistance and/or Diabetes-Induced Diastolic Dysfunction
03/20/2014US20140080788 Novel bicyclic nitrogen containing heteroaryl tgr5 receptor modulators
03/20/2014US20140080787 Method for the Treatment of Neuropathies Associated with Charcot-Marie-Tooth 1A (CMT1A) Disease
03/20/2014US20140080786 Medical and nutritional applications of highly refined cellulose
03/20/2014US20140080785 Methods for treatment or prevention of damage resulting from radiation, trauma or shock
03/20/2014US20140080784 Use of uridine and deoxyuridine to treat folate-responsive pathologies
03/20/2014US20140080783 Pharmaceutical combinations for treatment of specific cancers
03/20/2014US20140080782 Methods of diagnosing and treating pancreatic cancer
03/20/2014US20140080781 Composition of HMB and ATP and Methods of Use
03/20/2014US20140080780 identification of compounds that disperse tdp-43 inclusions
03/20/2014US20140080779 Macrocyclic lactones and use thereof
03/20/2014US20140080778 Use of secnidazole in treatment of dental infections
03/20/2014US20140080776 Composition and methods for extracting and using phytochemicals for the treatment of influenza
03/20/2014US20140080775 Molecular modulators of the wnt/beta-catenin pathway
03/20/2014US20140080774 Identification of free-b-ring flavonoids as potent cox-2 inhibitors
03/20/2014US20140080772 Treatments for melanoma
03/20/2014US20140080771 Method for treating rhinitis and sinusitis by rhamnolipids
03/20/2014US20140080770 Arylalkylamine compound and process for preparing the same
03/20/2014US20140080769 Substrate reduction therapy
03/20/2014US20140080767 Maternal sialic acid supplementation
03/20/2014US20140080766 Compositions and methods for macromolecular drug delivery
03/20/2014US20140080760 Combination therapy for treatment of cancer
03/20/2014US20140080759 Compositions comprising multivalent synthetic ligands of surface nucleolin and glycosaminoglycans
03/20/2014US20140080756 2,3-dihydro-1h-inden-1-yl-2,7-diazaspiro[3.5]nonane derivatives
03/20/2014US20140079836 Methods and compositions for altering health, wellbeing, and lifespan
03/20/2014US20140079835 Compositions containing resveratrol and essential oil of cloves for the treatment of itching
03/20/2014US20140079834 Bioactive fractions and compounds from dalbergia sissoo for the prevention or treatment of osteo-health related disorders
03/20/2014US20140079832 Methods and compositions for increasing growth hormones
03/20/2014US20140079831 Compositions for increasing human growth hormone levels
03/20/2014US20140079830 Methods for improving thyroid function in a subject
03/20/2014US20140079829 Methods and compositions for increasing sex steroids and growth hormones
03/20/2014US20140079828 Methods for increasing human growth hormone levels
03/20/2014US20140079827 Methods for improving health in animals
03/20/2014US20140079826 Compositions and methods for increasing human growth hormone levels
03/20/2014US20140079825 Methods for improving health in canines
03/20/2014US20140079824 Methods and compositions for increasing sex steroids and growth hormones
03/20/2014US20140079823 Methods for treating post-traumatic stress disorder
03/20/2014US20140079822 Methods for improving sleep efficiency in healthy human beings
03/20/2014US20140079821 Methods for improving health in humans
03/20/2014US20140079813 Genes Associated With Post Relapse Survival And Uses Thereof
03/20/2014US20140079812 Disulfide Chemotherapeutic Agents and Methods of Use Thereof
03/20/2014US20140079811 X-ray contrast media compositions and methods of using the same to treat, reduce or delay the onset of cns inflammation and inflammation associated conditions
03/20/2014US20140079810 X-ray contrast media compositions and methods of using the same
03/20/2014US20140079809 Compounds useful for the prevention or treatment of accommodative asthenopia
03/20/2014US20140079804 Compositions and methods for treatment of infections
03/20/2014US20140079793 Combinations and modes of administration of therapeutic agents and combination therapy
03/20/2014US20140079792 Coating composition suitable for pharmaceutical or nutraceutical dosage forms
03/20/2014US20140079791 Pharmaceutical preparations containing highly volatile silicones
03/20/2014US20140079788 Methods of treatment of pancreatic cancer
03/20/2014US20140079787 Methods for treating hepatocellular carcinoma
03/20/2014US20140079785 Composition comprising lipid nanoparticles and a corticosteroid or vitamin d derivative
03/20/2014US20140079784 Aerosolized lfa-1 antagonists for use in localized treatment of immune related disorders
03/20/2014US20140079783 Pharmaceutical Compositions Comprising Rifaximin and Amino acids, Preparation Methods and Use Thereof
03/20/2014US20140079782 Particulate materials
03/20/2014US20140079781 Pharmaceutical compositions
03/20/2014US20140079780 Crush resistant delayed-release dosage forms
03/20/2014US20140079779 Modified Release Tranexamic Acid Formulation
03/20/2014US20140079778 Pharmaceutical Formulations Including An Amine Compound
03/20/2014US20140079775 Agents to treat/prevent amoebiasis
03/20/2014US20140079774 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
03/20/2014US20140079772 Compositions and methods for the treatment of cancer
03/20/2014US20140079771 Methods and compositions for treatment of metabolic disorders
03/20/2014US20140079759 Fibrous polymer scaffolds having diametrically patterned polymer fibers
03/20/2014US20140079754 Microfabricated nanopore device for sustained release of therapeutic agent
03/20/2014US20140079741 Inhibition and treatment of biofilms
03/20/2014US20140079740 Oral transmucosal adminstration forms of s-ketamine
03/20/2014US20140079736 Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
1 ... 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 ... 7860